nach oben

Erschienen in:

2023 | OriginalPaper | Buchkapitel

4. Schmerztherapie in der Palliativmedizin

verfasst von : Otto Gehmacher, Rudolf Likar, Reinhard Sittl, Stefan Neuwersch-Sommeregger, Gebhard Mathis

Erschienen in: Palliativmedizin

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Schmerzen sind ein sehr komplexes Geschehen: Neben den biologischen Ursachen bestehen psychische, soziale und spirituelle Einflüsse auf Schmerzempfindung und Schmerzverarbeitung (total-pain-Konzept). Bei entsprechend differenzierter Wahrnehmung all dieser Bereiche kann eine gezielte, multiprofessionelle Behandlung erfolgen. Die medikamentöse Schmerztherapie hat sich vielfältig durch neue Substanzen und Verabreichungsformen entwickelt. Deren Einsatz erfordert gute Kenntnisse. In manchen Situationen sind lokale invasive Maßnahmen zielführender als nur systemische Therapien. Das weite Feld der nichtmedikamentösen Schmerzbehandlung setzt eine gewisse Rezeptivität der Leidenden und eine Authentizität der Behandler voraus. Dann stehen viele Zugänge offen: physiotherapeutisch, psychotherapeutisch und verschiedene Entspannungsverfahren.

American Geriatrics Society Panel (2009) Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 57(8):1331–1346CrossRef

Basmacioglu B, Aydinli I et al (2009) Effect of intravenous administration of paracetamol on morphine consumption in cancer pain control. Support Care Cancer 17(12):1475–1481CrossRef

Bennett MI, Laird B et al (2013) Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature. Pain Med 14:1681PubMedCrossRef

Bell RF, Eccleston C, et al. (2012) Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 11:CD003351

Beubler E (2012) Kompendium der medikamentösen Schmerztherapie-Wirkungen, Nebenwirkungen und Kombinationsmöglichkeiten. Springer, Wien (5. Aufl, S 23–25)

Bingel U, Schedlowski M (2015) Die Bedeutung von Placebomechansimen in der Schmerztherapie. In: Kress HG (Hrsg) Aktuelle Schmerzmedizin, economed Medizin. Verlagsgruppe Hüthig Jehle Rehm, Landsberg/Lech S, S 9–12

Breivik H, Cherny N et al. (2009) Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes Ann Oncol. 20(8):1420–33

Branford R, Wighton E et al (2010) Principles of drug therapy: focus on opioids. In: Hanks G, Cherni NI, Christakis NA, Fallon M, Kassa S, Portenoy RK (Hrsg) Oxford textbook of palliative medicine, 4. Aufl. Oxford Univerity Press, Oxford S, S 493–505

Brune K, Hinz B (2001) Nichtopioidanalgetika (antipyretische Analgetika und andere). In: Zenz M Jurna I (Hrsg) Lehrbuch der Schmerztherapie 2.Aufl. Wissenschaftliche Verlagsgesellschaft Stuttgart 233–253

Cherny NI, Cleary J et al (2013) The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology. Ann Oncol 24(11):7–13CrossRef

Coxib and traditional NSAID Trialists’ (CNT) Collaboration, (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382(9894):769–779CrossRef

Dahan A, Yassen A, Romberg R et al (2006) Buprenorphine induces ceiling in respiratory depression but not in analgesia Dahan. Br J Anaesth 96(5):627–632PubMedCrossRef

Dale O, Moksnes K, Kaasa S (2011) European palliative care research collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review. Palliat Med 25(5):494–503PubMedCrossRef

Davies AN, Dickman A, et al. (2009) Science committee of the association for palliative medicine of great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science committee of the association for palliative medicine of Great Britain and Ireland. Eur J Pain. 13(4):331–8

Derry S, Moore RA, et al. (2012) Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev

Eisenberg E, Marinangeli F et al (2005) Time to modify the WHO analgesic leader? Pain Clin Update. 13(5):1–4

Fallon MT (2013) Neuropathic pain in cancer, British. J Anesth 111(1):105–111

Farquhar-Smith WP (2009) Do cannabinoids have a role in cancer pain management? Curr Opin Support Palliat Care 3(1):7–13PubMedCrossRef

FDA Public Health Advisory (2012). Risk of burns during MRI scans from transdermal drug patches with metallic backings. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm111313.htm

Fine PG, Portenoy RK; Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation (2009) Establishing „best practices“ for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage 38(3):418–425CrossRef

Finnerup NB, Sindrup SH et al (2010) The evidence for pharmacological treatment of neuropathic pain. Pain 150:573–581PubMedCrossRef

Finnerup NB, Attal N et al (2015) Pharmacotherapy of neuropathic pain in adults: a systemic review and metaanalysis The. Lancet Neurol 14(2):162–173PubMedPubMedCentralCrossRef

Finniss DG, Benedetti F (2005) Mechanisms oft he placebo response and their impact on clinical trials and clinical practice. Pain 114(1–2):3–6PubMedCrossRef

Franceschi M, Scarcelli C et al (2008) Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 31(6):545–556PubMedCrossRef

Frohlich M, Gianotti A et al (2002) Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg 93:647–648CrossRef

Indelicato RA, Portenoy RK (2002) Opioid rotation in the management of refractory cancer pain. J Cin Oncol 20:348–352CrossRef

Klaschik E, Clemens KE (2005) Opioide in der Tumorschmerztherapie – Wirksamkeit und Nebenwirkungen. Schmerz 19:395–403PubMedCrossRef

Klinger R, Schedlowski M et al.(2010) Placebo Effekt in Schmerztherapie und –forschung. In Kröner–Herwig B, Frettlöh J, Klinger R, Nilges P (Hrsg) Schmerzpsychotherapie. Springer Berlin Heidelberg, S161–163

Kraft B, Kress HG (2008) Cannabinoide in der Schmerz und Palliativmedizin. In: Kress HG (Hrsg) Aktuelle Schmerzmedizin, economed Medizin. Verlagsgruppe Hüthig Jehle Rehm, Landsberg/Lech S, S 9–12

Lamberts M, Lip GYH et al (2014) Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. Ann Intern Med 161:690–698PubMedCrossRef

Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung (2015) Evidenztabellen 1.0, AWMF-Registernummer: 128/001OL. http://leitlinienprogramm-onkologie.de/Palliativmedizin.80.0.html

Likar R, Sittl R (2002) Praxis der transdermalen Schmerztherapie. UNI-MED, Bremen

Loke YK, Trivedi AN et al (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31–40PubMedCrossRef

Lux EA, Heine J (2011) Home care treatment of cancer pain patients with patient-controlled analgesia (PCA) Schmerz 25(6):663–7

Maltoni M, Scarpi E et al (2005) A validation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Cancer 13(11):888–894PubMedCrossRef

Marinangeli F, Ciccozzi A et al (2004) Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage 27(5):409–416PubMedCrossRef

Meier T, Wasner G et al (2003) Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 106(1–2):151–158PubMedCrossRef

Mercadante S, Nabal M et al. (2012) European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care (EAPC) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC, Lancet Oncol. Feb;13(2):e58–68

Mercadante S, Porzio G et al (2012) Tapentadol in cancer pain management: a prospective open-label study. Pain 28(11):1775–1779

Mishra S, Bhatnagar S et al (2012) A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care 29:177–182PubMedCrossRef

Mou J, Paillard F et al (2013) (2013) Efficacy of Qutenza® (capsaicin) 8 % patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database. Pain 154(9):1632–1639PubMedCrossRef

Nabal M, Librada S et al. (2011) The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med, 26(4): S. 305–12

Nauck F, Radbruch L (2011) Systemische medikamentöse Schmerztherapie. In: Aulbert E, Nauck F, RadbruchL (Hrsg) Lehrbuch der Palliativmedizin, Schattauer Verlag, 3. Aufl. Schattauer Verlag Stuttgart S 175–205

Nauck F, Klaschik E (2002) Schmerztherapie. Wissenschaftliche Verlagsgesellschaft Stuttgart, Kompendium für Ausbildung und Praxis

Okamoto Y, Tsuneto S et al (2013) Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer? Am J Hosp Palliat Care 30:450PubMedCrossRef

Okie S (2010) A flood of opioids, a rising tide of deaths. N Engl J Med Nov 18;363(21):1981–5

Pasero C (2007) IV opioid range orders for acute pain management. AJN 107(2):52–59PubMedCrossRef

Paulsen AN, Kaasa S et al (2013) Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review. J Pain Symptom Manage 46:96PubMedCrossRef

Portenoy RK, Ahmed E et al. (2015) Cancer pain management: Adjuvant analgesics(coanalgesics), UpToDate

Portenoy RK, Ahmed E et al. (2014) Cancer pain management: use of acetaminophin and nonsteroidal antiinflammatory drugs. UptoDate

Portenoy RK, Hagen NA (1990) Breakthrough pain: definition, prevalence and characteristics. Pain 41(3):273–281PubMedCrossRef

Portenoy RK, Ahmet E (2013) Adjuvant analgesics in management of cancer-related neuropathic pain, Encyclopedia of Pain, S 71–75

Radbruch L, Sabatowski R, et. al. (2001) Transdermal fentanyl fort he management of cancer pain: a survey of 1005 patients. Palliat Med 15:309–321PubMedCrossRef

Rezende RM, França DS et al (2008) Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain. Br J Pharmacol 153(4):760–768PubMedCrossRef

Rogosch T, Sinning C et al. (2012) Novel bioactive metabolites of dipyrone (metamizol), Bioorg Med Chem 1;20(1):101–7

Saunders CM (1978) The management of terminal malignant disease, 1. Aufl. Edward Arnold, London

Schick V, Schulz HJ (2010) Nichtsteroidale Antirheumatika und Gastrointestinaltrakt. Gastroenterologie 5:461–472CrossRef

Schubert I, Ihle P et al (2013). Zunahme der Opioidverordnungen in Deutschland zwischen 2000 und 2010: Eine Studie auf der Basis von Krankenkassendaten, Dtsch Arztebl Int 110(4):45-51.

Smith HS, Peppin JF (2014) Toward a systematic approach to opioid rotation. J Pain Res 7:589–608PubMedPubMedCentral

Stockler M, Vardy J et al (2004) Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol 22(16):3389–3394PubMedCrossRef

Svendsen KB, Andersen S et al (2005) Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 9(2):195–206PubMedCrossRef

Tassinari D, Sartori S et al (2008) Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature. J Palliat Med 11(3):492–501PubMedCrossRef

Tremont-Lukats IW, Challapalli V et al (2005) Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 101:1738PubMedCrossRef

Twycross R (1999) Opioids. In: Wall PD, Melzack R (Hrsg) Textbook of pain. 4th Aufl. Churchill Livingston, Edinburgh London S 1187–1214

Vaile JH, Davis P(1998) Topical NSAIDs for musculoskeletal conditions, Drugs Nov 56(5):793–799

Van den Beuken-vanEverdingen MHJ, de Rijke JM et al (2007) Prevalence of pain in patients with cancer:a systemic review oft he past 40 years. Ann Oncol 18(9):1437–1449CrossRef

Vargas-Schaffer G (2010) Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 56(6):514–517PubMedPubMedCentral

Weber LM, Ghafoor VL et al (2008) Implementation of standard order sets for patient-controlled analgesia. Am J Health Syst Pharm 65(12):1184–1191PubMedCrossRef

WHO (1996) Cancer pain relief, with a guide to opioid availability. World Health Organization, Geneva

Wong MH, Stockler MR et al. (2012) Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev 2:CD003474

Zech DF, Grond S et al (1995) Validation of World Health Organization guidelines for cancer pain relief: a 10 year prospective study. Pain 63(1):65–76PubMedCrossRef

Zeppetella G, Davies AN (2013) Opioids for the management of breakthrough pain in cancer patients. Cochrane Database Syst Rev. 10:CD004311

Amesbury B, O’Riordan J (1999) The use of interpleural analgesia using bupivacaine for pain relief in advanced cancer. Palliat Med 13(2):153–158PubMedCrossRef

Baker L, Lee M, Regnard C et al (2004) Evolving spinal alagesia practice in palliative Care. Palliat Med 18:507–515PubMedCrossRef

Ballantyne JC et al (1996) Comparative efficacy of epidural, subarachnoid and Intracerebro-ventricular opioids in patients with pain due to cancer. Reg Anesth 21(6):542–556PubMed

Cleary JF (2000) Cancer pain management. Cancer Control 7(2):120–131PubMedCrossRef

Deer TR, Prager J, Levy R et al (2012) Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel; Neuromodulation

Eisenberg E, Carr DB, Chalmers TC (1995) Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis Anesth Anal. 1995 Feb; 80(2):290–5

Lema MJ (2001) Invasive analgesia techniques for advanced cancer pain. Surg Oncol Clin N Am 10(1):127–136PubMedCrossRef

Lynch J, Zech D, Grond S (1992) The role of intrathecal neurolysis in the treatment of cancer-related perianal and perineal pain. Palliat Med 6(2):140–145CrossRef

Mummenthaler M et al (Hrsg) (1990) Treatment of chronic pain: possibilities, limitations and long-term follow-up. Harwood, London

Nagels W, Pease N, Bekkering G (2013) Celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med 14:1140–1163PubMedCrossRef

Nitescu P, Applegren L, Lindler L (1990) Epidural versus intrathecal morphine bupivacaine: assessment of consecutive treatments in advanced cancer pain. J Pain Syndrom Manag 5:18–26CrossRef

Plancarte R, de Leon-Casasola OA, El-Helaly M et al (1997) Neurolytic superior hypogastric plexus block for chronic pain associated with cancer. Reg Anaesth 22:562–568

Raphael J, Hester J, Ahmedzai S et al (2010) Cancer pain: part 2: physical, interventional and complimentary therapies, management in the community; acute, treatment-related and complex cancer pain; a perspective from the British pain society endorsed by the UK association of palliative medicine and the royal college of general practitioners. Pain Med 11:872–896PubMedCrossRef

Shankar H, Khatri V, Eastwood D (2010) Retrospektive comparison of ultrasound and fluoroscopie image guidance for intercostal steroid injections. Pain Pract 10(4):312–317PubMedCrossRef

Smith TJ, Staats PS, Deer T et al (2002) Implantable drug delivery systems study group. Randomised clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain; impact on pain, drug related toxicity and survival. J Clin Oncol 20:4040–4049PubMedCrossRef

Vissers KCP, van den Brand MWM, Jacobs J et al (2013) Palliative medicine update: a multidisciplinary approach. Pain Pract 13(7):576–588PubMedCrossRef

Williams JE, Louw G, Towlerton G (2000) Intrathecal pumps for giving opioids in chronic pain: a systematic review. Health Technol Assess 4(32):1–65PubMedPubMedCentralCrossRef

Wong FCS, Lee TW, Yuen KK et al (2007) Intercostal nerve blockade for cancer pain: effectiveness and selection of patients. Hong Kong Med J 13:266–270PubMed

Yamamuro M, Kusaka K, Kato M, Takahashi M (2000) Celiac plexus block in cancer pain management. Tohoku J Exp Med 192:1–18PubMedCrossRef

Yan BM, Myers RP (2007) Neurolytic celiac plexus block for pain control in unresectable pancreatic. Cancer Am J Gastroenterol 102(2):430–438PubMedCrossRef

AWMF- Leitlinienprogramm Onkologie | S3-Leitlinie Komplementärmedizin | Kurzversion 1.1 | September 2021

Basler HD, Kröner-Herwig B et al (2003) Pychologische Schmerztherapie 5. Aufl. Springer, Heidelberg

Bernatzky G, Presch M, Anderson M, Panksepp J (2011) Emotional foundations of music as a non-pharmacological pain management tool in modern medicine. Neurosci Biobehav Rev 35:1889–1899CrossRef

Bernatzky G, Hesse HP ( 2012) Musik therapie. In: Bernatzky G., Sittl R., Likar R. (Hrsg.) Schmerzbehandlung in der Palliativmedizin 3., überarb Aufl Springer Wien S 229–234

Bernatzky G, Wendtner F, Flock T (2014) Entspannung bei Stress 2, Wohlfühl-CD zum Entschleunigen, Entspannen und Regenerieren. Musik mit Entspannungsanleitung; Audio CD © Spield.: 51:16 min, Verlag clara lumina

Bernstein DA, Borkovec TD (2000) Entspannungstraining. Handbuch der progressiven Muskelentspannung nach Jacobson Klett-Cotta, Stuttgart

Erickson MH (1959) Hypnosis in painful terminal illness. Am J Clin Hypn 1:117–121CrossRef

Gatterer G (2009) Progressive Muskelentspannung nach Jacobson. In: Likar R, Bernatzky G, Märkert D, Ilias W (Hrsg) Schmerztherapie in der Pflege, Springer Wien

Jensen KB, Petrovic P, Kerr C et al (2014) Sharing pain relief: neural correlates od physicians during treatment of patients. Mol Psychiatry 19:392–398PubMedCrossRef

Kaiser-Rekkas A (2009) Hypnosetherapie beim Schmerz. In: Likar R, Bernatzky G. Schmerztherapie in der Pflege. Springer Wien NewYork; 241–247

Kant I (1998) Kritik der reinen Vernunft. Meiner Verlag, Hamburg, S 1998CrossRef

Nieland P (2009) Physiotherapie in der Palliativmedizin. Z Palliativmed 10:85–101CrossRef

Petrovic P, Kalso E, Petersson KM, Ingvar M (2002) Placebo and opioid analgesia – imaging a shared neuronal network. Science 295:1737–1740PubMedCrossRef

Petzold H (2004) Integrative Therapie. Modelle, Theorien und Methoden einer schulenübergreifenden Psychotherapie, 3 Bd, 2. Auf, Junfermann, Paderborn

Revenstorf D (2006) Expertise zur Beurteilung der wissenschaftlichen Evidenz des Psychotherapieverfahrens Hypnotherapie entsprechend den Kriterien des Wissenschaftlichen Beirats Psychotherapie. Hypnose ZHH Band 1 und 2

Rogge AA, Baur I, Blettner G, Holtkamp U, Horneber M, Jahn P et al (2020) Defining criteria for guiding cancer patients to find a reputable complementary medicine provider: results of a literature review and a consensus procedure. Patient Prefer Adherence 14:747PubMedPubMedCentralCrossRef

Schultz JH (1932) Das autogene Training (konzentrative Selbstentspannung). Versuch einer klinisch-praktischen Darstellung. Thieme, Leipzig

Schulze W (2013) Hypnose und Hypnotherapie in der Palliativmedizin – Symptombehandlung und spirituelle Begleitung. Z. Palliativmed 14:59–72

Witt CM, Balneaves LG, Carlson LE, Cohen M, Deng G, Fouladbakhsh JM, et al. (2020) Education competencies for integrative oncology—results of a systematic review and an international and interprofessional consensus procedure. J. Cancer Edu. 2020:1–9

Titel: Schmerztherapie in der Palliativmedizin
verfasst von: Otto Gehmacher
Rudolf Likar
Reinhard Sittl
Stefan Neuwersch-Sommeregger
Gebhard Mathis
Verlag: Springer Berlin Heidelberg
Buch: Palliativmedizin
Print ISBN: 978-3-662-65767-6

Electronic ISBN: 978-3-662-65768-3

Copyright-Jahr: 2023
DOI: https://doi.org/10.1007/978-3-662-65768-3_4

Springer Medizin

4. Schmerztherapie in der Palliativmedizin

Zusammenfassung

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie